Skip to content

Candlr

All Your Cannabis & Psychedelic News in One Place

Tag: Food & Drug Administration

FDA Approves New Indication for Drug Containing an Active Ingredient Derived from Cannabis to Treat Seizures in Rare Genetic Disease

Continue reading →

Revive Therapeutics Announces U.S. FDA Approval of Confirmatory Phase 3 Clinical Trial for Bucillamine in COVID-19

Continue reading →

Tetra Bio-Pharma Receives Conditional Approval to Graduate to the TSX

Continue reading →

June 19, 2020October 2, 2020

Naturally Splendid Provides Clinical Trial Application Update

Continue reading →

June 9, 2020October 2, 2020

Charlotte’s Web Steps up to Support Research to Address FDA’s Request for More Scientific Data

Continue reading →

Menu

Home
About Candlr
- Legal Disclaimer
- Services
Blog
News
Featured Companies
Psychedelic Sector
Cannabis Sector
Contact

Get Early Access

Enter your email address to get early access to Candlr app.

Join 4,114 other followers

Email Address:

About Candlr

Candlr is an Investment & Marketing firm developing the best in class stock screener app for traders and investors.

For early access to Candlr app please subscribe HERE.

Hours & Info

1161 W Georgia St, Vancouver, BC V6E 0C6

Info@cannabis-investment-group.com

Follow Blog via Email

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 4,114 other followers

Email Address: